Morgan Stanley Makes Bullish Call on Valeant (VRX); Rating Raised to 'Overweight'
Tweet Send to a Friend
(Updated - August 17, 2016 10:46 AM EDT)Morgan Stanley upgraded Valeant Pharmaceuticals (NYSE: VRX) from Equalweight to Overweight with a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
